Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Ciproxin Solution for Infusion 2 mg/ml - PA1410/028/007
- Estradot 37.5mcg/24 hours, Transdermal Patch - PA0896/010/001
- Estradot 50mcg/24 hours, Transdermal Patch - PA0896/010/002
- Flucol 50mg Hard capsules - PA0711/057/001
- Letzo 2.5mg Tablets - PA0711/190/001
- Septrin 80mg/400mg per Ampoule, Concentrate for Solution for Infusion - PA1691/010/005
- Orencia 125mg/ml Solution for Injection Pre Filled Pen - EU/1/07/389/011
- Telfast 120mg Film Coated Tablets - PA23180/003/002
- Xarelto 1mg/ml Granules for Oral Suspension - EU/1/08/472/050-051
- Zyvox 2mg/ml Solution for Infusion - PA0822/143/002
The following shortages have been resolved and supply has resumed to the Irish market:
- Chlorhexidine acetate 0.015% w/v and Cetrimide 0.15% w/v Irrigation Solution - PA2299/005/001
- Ciprofloxacin 2 mg/ml Solution for Infusion - PA1122/005/001
- Co-amoxiclav 500mg/100mg Powder for Solution for Injection/Infusion - PA1457/001/001
- Co-amoxiclav 1000mg/200mg Powder for Solution for Injection/Infusion - PA1457/001/002
- Depo-Provera 150mg/ml Suspension for Injection - PA0822/124/001
- Esomeprazole Ticerin 40mg Powder for Solution for Injection or Infusion - PA1852/002/001
- Ezetimibe/Simvastatin Clonmel 10mg/80mg Tablets - PA0126/281/004
- Innohep 2500IU/ml Solution for Injection - PA0046/060/008
- Letrozole 2.5mg Film Coated Tablets - PA2315/109/001
- Letrozole 2.5mg Film Coated Tablets - PA0126/198/001
- Letrozole Teva 2.5mg Film Coated Tablets- PA0749/085/001
- Molaxole Powder for Oral Solution - PA2010/025/001
- Monotrim 100mg Tablets - PA22643/002/002
- Ondansetron 2mg/ml Solution for Injection or Infusion - PA0577/083/001
- Phenergan 5mg/5ml Oral Solution - PA23180/011/001
- Relpax 40mg Film Coated Tablets - PA23055/002/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.